ATLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration

Blood

Volumn 113, Issue 18, 2009, Pages 4224-4231

  McKimmie, Clive S ^a   Moore, Mark ^a   Fraser, Alasdair R ^a   Jamieson, Thomas ^b   Xu, Damo ^a   Burt, Claire ^a   Pitman, Nick I ^a   Nibbs, Robert J ^a   McInnes, Iain B ^a   Liew, Foo Y ^a   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN; TOLL LIKE RECEPTOR 2; CHEMOKINE; GAMMA INTERFERON; LIGAND; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED DISORDER; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; FEMALE; FLOW CYTOMETRY; INFLAMMATION; INTERFERON-GAMMA; LEUKOCYTES; LIGANDS; LIPOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTOR 2;

EID: 66149112109     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-08-174698     Document Type: Article

References (42)

1. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979-987; quiz 988.
2. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol. 2006;18:3-9.
3. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891-928. (Pubitemid 38680444)
4. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999;20:254-257. (Pubitemid 29258161)
5. Akdis CA, Kussebi F, Pulendran B, et al. Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol. 2003;33:2717-2726. (Pubitemid 37337137)
6. Hollingsworth JW, Whitehead GS, Lin KL, et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol. 2006;176:5856-5862.
7. Patel M, Xu D, Kewin P, et al. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol. 2005;174:7558-7563. (Pubitemid 40806259)
8. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance. Biochem Biophys Res Commun. 2006;339:1048-1055. (Pubitemid 41790570)
9. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A. 2004;101:3029-3034. (Pubitemid 38327729)
10. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005;6:403-411. (Pubitemid 41716781)
11. McKimmie CS, Fazakerley JK. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J Neuroimmunol. 2005;169:116-125.
12. Martinez de la Torre Y, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol. 2005;35:1342-1346. (Pubitemid 40691415)
13. Nibbs RJ, Gilchrist DS, King V, et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest. 2007;117:1884-1892.
14. Graham GJ, McKimmie CS. Chemokine scavenging by D6: a movable feast? Trends Immunol. 2006;27:381-386.
15. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol. 2004;173:7548-7555. (Pubitemid 39628196)
16. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007;7:353-364.
17. Pierce JW, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997;272:21096-21103. (Pubitemid 27373968)
18. Barlic J, Zhang Y, Murphy PM. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner. J Biol Chem. 2007;282:19167-19176. (Pubitemid 47100191)
19. Fernández-Majada V, Aguilera C, Villanueva A, et al. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A. 2007;104:276-281. (Pubitemid 46068022)
20. Torgler R, Bongfen SE, Romero JC, Tardivel A, Thome M, Corradin G. Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression. J Immunol. 2008;180:3990-3999.
21. Wu S, Flint JK, Rezvani G, De Luca F. Nuclear factor-kappaB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem. 2007;282:33698-33706.
22. Zhan Y, Gerondakis S, Coghill E, et al. Glucocorticoid-induced TNF receptor expression by T cells is reciprocally regulated by NF-kappaB and NFAT. J Immunol. 2008;181:5405-5413.
23. Hariharan D, Douglas SD, Lee B, Lai JP, Campbell DE, Ho WZ. Interferon-gamma upregulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood. 1999;93:1137-1144. (Pubitemid 29076127)
24. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood. 2003;102:2660-2669. (Pubitemid 37193610)
25. Sabroe I, Jones EC, Whyte MK, Dower SK. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology. 2005;115:90-98. (Pubitemid 40593295)
26. Franchin G, Zybarth G, Dai WW, et al. Lipopolysaccharide inhibits HIV-1 infection of monocytederived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J Immunol. 2000;164:2592-2601. (Pubitemid 30115490)
27. Xu L, Khandaker MH, Barlic J, et al. Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression. Eur J Immunol. 2000;30:227-235.
28. Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol. 2004;172:4977-4986. (Pubitemid 38456424)
29. Sica A, Saccani A, Borsatti A, et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med. 1997;185:969-974. (Pubitemid 27119881)
30. Sozzani S, Allavena P, D'Amico G, et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol. 1998;161:1083-1086. (Pubitemid 28380531)
31. Sallusto F, Schaerli P, Loetscher P, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998;28:2760-2769. (Pubitemid 28425234)
32. Schwartz-Cornil I, Epardaud M, Albert JP, et al. Probing leukocyte traffic in lymph from oro-nasal mucosae by cervical catheterization in a sheep model. J Immunol Methods. 2005;305:152-161. (Pubitemid 41416710)
33. Harmsen AG, Mason MJ, Muggenburg BA, Gillett NA, Jarpe MA, Bice DE. Migration of neutrophils from lung to tracheobronchial lymph node. J Leukoc Biol. 1987;41:95-103.
34. Cao C, Lawrence DA, Strickland DK, Zhang L. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood. 2005;106:3234-3241. (Pubitemid 41565924)
35. Debes GF, Arnold CN, Young AJ, et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. 2005;6:889-894.
36. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. 2005;6:895-901. (Pubitemid 43090444)
37. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106-115.
38. Lau S, Matricardi PM. Worms, asthma, and the hygiene hypothesis. Lancet. 2006;367:1556-1558.
39. Vercelli D. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr Opin Immunol. 2006;18:733-737.
40. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1:69-75. (Pubitemid 33741977)
41. Yang X, Wang S, Fan Y, Zhu L. Systemic mycobacterial infection inhibits antigen-specific immunoglobulin E production, bronchial mucus production and eosinophilic inflammation induced by allergen. Immunology. 1999;98:329-337. (Pubitemid 29526953)
42. Lagranderie M, Abolhassani M, Vanoirbeek J, et al. Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models. J Allergy Clin Immunol. 2008;121:471-478. (Pubitemid 351215172)